This company listing is no longer active
PBP Overzicht aandelen
Engages in the development, manufacture, packing, distribution, and sale of prescription and over the counter pharmaceuticals, complementary medicines and consumer health products, and fast-moving consumer products in Australia and internationally.
| Sneeuwvlok Score | |
|---|---|
| Waardering | 2/6 |
| Toekomstige groei | 1/6 |
| Prestaties in het verleden | 2/6 |
| Financiële gezondheid | 4/6 |
| Dividenden | 1/6 |
Probiotec Limited Concurrenten
Prijsgeschiedenis en prestaties
| Historische aandelenkoersen | |
|---|---|
| Huidige aandelenkoers | AU$2.98 |
| 52 Week Hoogtepunt | AU$3.03 |
| 52 Week Laag | AU$2.14 |
| Bèta | 0.47 |
| 11 maand verandering | 2.05% |
| 3 maanden verandering | 6.81% |
| 1 Jaar Verandering | 11.61% |
| 33 jaar verandering | 39.91% |
| 5 jaar verandering | 91.03% |
| Verandering sinds IPO | 158.01% |
Recent nieuws en updates
Rendement voor aandeelhouders
| PBP | AU Pharmaceuticals | AU Markt | |
|---|---|---|---|
| 7D | 0% | -4.1% | -2.0% |
| 1Y | 11.6% | 78.0% | 20.0% |
Rendement versus industrie: PBP underperformed the Australian Pharmaceuticals industry which returned 63.2% over the past year.
Rendement versus markt: PBP exceeded the Australian Market which returned 6.1% over the past year.
Prijsvolatiliteit
| PBP volatility | |
|---|---|
| PBP Average Weekly Movement | 1.8% |
| Pharmaceuticals Industry Average Movement | 11.4% |
| Market Average Movement | 8.7% |
| 10% most volatile stocks in AU Market | 17.6% |
| 10% least volatile stocks in AU Market | 3.6% |
Stabiele aandelenkoers: PBP has not had significant price volatility in the past 3 months.
Volatiliteit in de loop van de tijd: PBP's weekly volatility (2%) has been stable over the past year.
Over het bedrijf
| Opgericht | Werknemers | CEO | Website |
|---|---|---|---|
| 1996 | n/a | Wes Stringer | www.probiotec.com.au |
Probiotec Limited Samenvatting
| PBP fundamentele statistieken | |
|---|---|
| Marktkapitalisatie | AU$242.34m |
| Inkomsten(TTM) | AU$8.69m |
| Inkomsten(TTM) | AU$221.22m |
27.9x
Koers/Winstverhouding1.1x
P/S-verhoudingIs PBP overgewaardeerd?
Zie Reële waarde en waarderingsanalyseInkomsten en omzet
| PBP resultatenrekening (TTM) | |
|---|---|
| Inkomsten | AU$221.22m |
| Kosten van inkomsten | AU$154.96m |
| Brutowinst | AU$66.25m |
| Overige uitgaven | AU$57.57m |
| Inkomsten | AU$8.69m |
Laatst gerapporteerde inkomsten
Dec 31, 2023
Volgende inkomensdatum
n.v.t.
| Winst per aandeel (EPS) | 0.11 |
| Brutomarge | 29.95% |
| Nettowinstmarge | 3.93% |
| Schuld/Eigen Vermogen Verhouding | 52.5% |
Hoe presteerde PBP op de lange termijn?
Bekijk historische prestaties en vergelijking